Stockholders' Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	May 28, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Stockholders Equity [Line Items]
Common stock, shares outstanding		38,410,935		38,345,140
Proceeds from issuance of common stock		$ 0	$ 1
Convertible preferred stock, shares issued upon conversion		18,811,552
Preferred stock, shares authorized		10,000,000
Common stock, shares issued		38,410,935		38,345,140
Preferred stock, shares outstanding		10,248		10,248
Stock-based compensation		$ 2,112	$ 1,772
Common stock, shares authorized		400,000,000		400,000,000
Restricted Stock Units [Member]
Stockholders Equity [Line Items]
Unrecognised compensation expense related to unvested units		$ 600
Restricted Stock units plan weighted average vesting period		2 years 2 months 12 days
Share-Based Payment Arrangement, Option [Member]
Stockholders Equity [Line Items]
Stock option plan weighted average vesting period		2 years 10 months 24 days
Unrecognised compensation expense related to unvested units		$ 16,600
Series E and Series F Convertible Preferred Stock [Member]
Stockholders Equity [Line Items]
Percentage of outstanding common stock		9.98%
Series E Convertible Preferred Stock [Member]
Stockholders Equity [Line Items]
Price per common share		$ 500
Preferred stock, shares outstanding		1,915
Convertible share price per share		$ 17.50
Series F Convertible Preferred Stock [Member]
Stockholders Equity [Line Items]
Price per common share		$ 600
Preferred stock, shares outstanding		8,333
Convertible share price per share		$ 21.00
Common Stock [Member]
Stockholders Equity [Line Items]
Common stock, shares issued		0	0
Shares issued		38,411	37,486	38,345	37,425
Sales Agreement [Member]
Stockholders Equity [Line Items]
Common stock par value	$ 0.0001
Sales Agreement [Member] | Maximum [Member]
Stockholders Equity [Line Items]
Potential sales of common stock	$ 50,000